- Home
- ONCY vs ILLR Comparison
ONCY vs ILLR Comparison
Compare ONCY & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ILLR
- Stock Information
- Founded
- ONCY 1998
- ILLR 2015
- Country
- ONCY Canada
- ILLR United States
- Employees
- ONCY N/A
- ILLR N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ILLR Investment Managers
- Sector
- ONCY Health Care
- ILLR Finance
- Exchange
- ONCY Nasdaq
- ILLR Nasdaq
- Market Cap
- ONCY 89.7M
- ILLR 79.7M
- IPO Year
- ONCY 1999
- ILLR N/A
- Fundamental
- Price
- ONCY $1.35
- ILLR $1.48
- Analyst Decision
- ONCY Strong Buy
- ILLR
- Analyst Count
- ONCY 5
- ILLR 0
- Target Price
- ONCY $5.00
- ILLR N/A
- AVG Volume (30 Days)
- ONCY 1.2M
- ILLR 3.3M
- Earning Date
- ONCY 11-11-2025
- ILLR 11-13-2025
- Dividend Yield
- ONCY N/A
- ILLR N/A
- EPS Growth
- ONCY N/A
- ILLR N/A
- EPS
- ONCY N/A
- ILLR N/A
- Revenue
- ONCY N/A
- ILLR $45,244,000.00
- Revenue This Year
- ONCY N/A
- ILLR N/A
- Revenue Next Year
- ONCY N/A
- ILLR N/A
- P/E Ratio
- ONCY N/A
- ILLR N/A
- Revenue Growth
- ONCY N/A
- ILLR N/A
- 52 Week Low
- ONCY $0.33
- ILLR $0.40
- 52 Week High
- ONCY $1.53
- ILLR $6.52
- Technical
- Relative Strength Index (RSI)
- ONCY 64.00
- ILLR 85.58
- Support Level
- ONCY $1.20
- ILLR $0.61
- Resistance Level
- ONCY $1.44
- ILLR $0.76
- Average True Range (ATR)
- ONCY 0.11
- ILLR 0.15
- MACD
- ONCY 0.01
- ILLR 0.10
- Stochastic Oscillator
- ONCY 79.07
- ILLR 100.00
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.